Disclosed herein are compounds that inhibit Bruton's tyrosine kinase (Btk). Also described are irreversible inhibitors of Btk. In addition, reversible inhibitors of Btk are also described. Also disclosed are pharmaceutical compositions that include the compounds. Methods of using the Btk inhibitors are disclosed, alone or in combination with other therapeutic agents, for the treatment of autoimmune diseases or conditions, heteroimmune diseases or conditions, cancer, including lymphoma, and inflammatory diseases or conditions.
本文披露了抑制布鲁顿
酪氨酸激酶(Btk)的化合物。还描述了Btk的不可逆
抑制剂。此外,还描述了Btk的可逆
抑制剂。还披露了包括这些化合物的药物组合物。披露了使用Btk
抑制剂的方法,单独或与其他治疗剂联合治疗自身免疫疾病或症状、异源免疫疾病或症状、癌症(包括淋巴瘤)和炎症性疾病或症状。